Khiron Life Sciences (KHRNF) Financial Statements
Khiron Life Sciences Financial Overview
Khiron Life Sciences's market cap is currently $5.14M. The company's EPS TTM is $-0.17; its P/E ratio is -0.20; Khiron Life Sciences is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
| Mar 22 | Mar 21 | Mar 20 | Mar 19 | May 17 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 12.79M | $ 8.02M | $ 9.58M | $ 891.68K | $ 0.00 |
| Gross Profit | $ 6.37M | $ 7.01M | $ 2.44M | $ 297.36K | $ 0.00 |
| Operating Income | $ -19.79M | $ -23.60M | $ -37.43M | $ -19.90M | $ 0.00 |
| EBITDA | $ -32.03M | $ -22.32M | $ -36.49M | $ -18.29M | $ -4.52M |
| Net Income | $ -33.13M | $ -24.04M | $ -36.38M | $ -19.81M | $ 0.00 |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 8.92M | $ 21.65M | $ 36.90M | $ 18.96M | $ 147.52K |
| Total Assets | $ 42.27M | $ 73.18M | $ 81.91M | $ 40.35M | $ 147.52K |
| Total Debt | $ 2.23M | $ 2.79M | $ 3.55M | $ 2.51M | $ 0.00 |
| Net Debt | $ -6.70M | $ -18.86M | $ -5.79M | $ -12.51M | $ -147.52K |
| Total Liabilities | $ 8.95M | $ 9.95M | $ 11.87M | $ 14.81M | $ 12.62K |
| Stockholders' Equity | $ 33.33M | $ 63.23M | $ 70.04M | $ 25.54M | $ 134.90K |
| Cash Flow | |||||
| Free Cash Flow | $ -22.14M | $ -27.23M | $ -36.17M | $ -18.60M | $ -21.30K |
| Operating Cash Flow | $ -20.40M | $ -24.53M | $ -30.07M | $ -14.77M | $ -21.30K |
| Investing Cash Flow | $ -2.09M | $ 24.87M | $ -31.98M | $ -9.22M | $ 0.00 |
| Financing Cash Flow | $ 10.89M | $ 12.17M | $ 57.00M | $ 37.59M | $ 5.00K |
Currency in CAD